Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species
- PMID: 20372925
- DOI: 10.1007/s00436-010-1852-8
Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species
Abstract
In the present study, we selected in vitro populations of Leishmania Viannia guyanensis, L.V. braziliensis, L. Leishmania amazonensis and L.L. infantum chagasi that were resistant to potassium antimony tartrate (SbIII). The resistance index of these populations varied from 4- to 20-fold higher than that of their wild-type counterparts. To evaluate the stability of the resistance phenotype, these four resistant populations were passaged 37 to 47 times in a culture medium without SbIII. No change was observed in the resistance indexes of L.V. guyanensis (19-fold) and L.L. infantum chagasi (4-fold). In contrast, a decrease in the resistance index was observed for L.V. braziliensis (from 20- to 10-fold) and L.L. amazonensis (from 6- to 3-fold). None of the antimony-resistant populations exhibited cross-resistance to amphotericin B and miltefosine. However, the resistant populations of L.V. braziliensis, L.L. amazonensis and L.L. infantum chagasi were also resistant to paromomycin. A drastic reduction was observed in the infectivity in mice for the resistant L.V. guyanensis, L.L. amazonensis and L.V. braziliensis populations. The SbIII-resistant phenotype of L.V. braziliensis was stable after one passage in mice. Although the protocol of induction was the same, the SbIII-resistant populations showed different degrees of tolerance, stability, infectivity in mice and cross-resistance to antileishmanial drugs, depending on the Leishmania species.
Similar articles
-
Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony.Int J Parasitol Drugs Drug Resist. 2013 Sep 5;3:143-53. doi: 10.1016/j.ijpddr.2013.08.001. eCollection 2013 Dec. Int J Parasitol Drugs Drug Resist. 2013. PMID: 24533304 Free PMC article.
-
In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.J Antimicrob Chemother. 2014 Jan;69(1):150-4. doi: 10.1093/jac/dkt318. Epub 2013 Aug 22. J Antimicrob Chemother. 2014. PMID: 23970484
-
Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines.Mol Biochem Parasitol. 2013 Aug;190(2):63-75. doi: 10.1016/j.molbiopara.2013.06.006. Epub 2013 Jul 4. Mol Biochem Parasitol. 2013. PMID: 23831370
-
Cutaneous leishmaniasis treatment.Travel Med Infect Dis. 2007 May;5(3):150-8. doi: 10.1016/j.tmaid.2006.09.004. Epub 2006 Oct 31. Travel Med Infect Dis. 2007. PMID: 17448941 Review.
-
Progress in antileishmanial drugs: Mechanisms, challenges, and prospects.PLoS Negl Trop Dis. 2025 Jan 3;19(1):e0012735. doi: 10.1371/journal.pntd.0012735. eCollection 2025 Jan. PLoS Negl Trop Dis. 2025. PMID: 39752369 Free PMC article. Review.
Cited by
-
Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis.PLoS Negl Trop Dis. 2011 May;5(5):e1167. doi: 10.1371/journal.pntd.0001167. Epub 2011 May 24. PLoS Negl Trop Dis. 2011. PMID: 21629719 Free PMC article.
-
Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.Antimicrob Agents Chemother. 2016 Jul 22;60(8):4482-9. doi: 10.1128/AAC.00768-16. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27161624 Free PMC article.
-
Targeting p53 pathways: mechanisms, structures, and advances in therapy.Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1. Signal Transduct Target Ther. 2023. PMID: 36859359 Free PMC article.
-
Ascorbate peroxidase overexpression protects Leishmania braziliensis against trivalent antimony effects.Mem Inst Oswaldo Cruz. 2018 Nov 14;113(12):e180377. doi: 10.1590/0074-02760180377. Mem Inst Oswaldo Cruz. 2018. PMID: 30507997 Free PMC article.
-
Translational reprogramming as a driver of antimony-drug resistance in Leishmania.Nat Commun. 2023 May 5;14(1):2605. doi: 10.1038/s41467-023-38221-1. Nat Commun. 2023. PMID: 37147291 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources